Ost-müük NuVasive - NUVA CFD
Lisa lemmikuks- Kokkuvõte
- Ajaloolised andmed
- Sündmused
- Tuluaruanne
- Bilanss
- Rahavood
- Omand
Hinnavahe | 0.35 | ||||||||
Pika positsiooni ööpäeva tasu
Long position overnight fee
Mine platvormile | -0.024068% | ||||||||
Lühikese positsiooni ööpäeva tasu
Short position overnight fee
Mine platvormile | 0.001846% | ||||||||
Ööpäeva tasu aeg | 21:00 (UTC) | ||||||||
Min kauplemise kogus | 1 | ||||||||
Valuuta | USD | ||||||||
Tagatis | 20% | ||||||||
Aktsiabörs | United States of America | ||||||||
Kauplemise vahendustasu | 0% |
*Information provided by Capital.com
Eelmine sulgemine* | 51.96 |
Avatud* | 51.73 |
Aastane muutus* | -1.52% |
Päeva ulatus* | 51.73 - 52.64 |
52 nädala ulatus | 35.17-60.47 |
Keskmine maht (10 päeva) | 1.01M |
Keskmine maht (3 kuud) | 21.24M |
Turukapitalisatsioon | 1.98B |
P/E suhtarv | 64.84 |
Ringluses olevad aktsiad | 52.19M |
Tulu | 1.20B |
EPS | 0.59 |
Dividendid (% kasumist) | N/A |
Beeta | 1.08 |
Järgmine tuluaruande kuupäev | May 2, 2023 |
Kõigi andmete allikas on Refinitiv, välja arvatud tärniga märgitud, kus *-ga andmed on esitanud Capital.com
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | Close | Sulgemishind | Change (%) | Avamishind | High | Low |
---|---|---|---|---|---|---|
Dec 31, 2021 | 52.32 | 1.50 | 2.95% | 50.82 | 52.75 | 50.61 |
Dec 30, 2021 | 51.96 | 1.08 | 2.12% | 50.88 | 53.44 | 50.52 |
Dec 29, 2021 | 52.47 | 1.46 | 2.86% | 51.01 | 53.15 | 51.01 |
Dec 28, 2021 | 51.76 | 0.33 | 0.64% | 51.43 | 53.17 | 50.66 |
Dec 27, 2021 | 52.55 | 1.24 | 2.42% | 51.31 | 52.70 | 51.30 |
Dec 23, 2021 | 52.18 | 1.43 | 2.82% | 50.75 | 52.81 | 50.02 |
Oct 11, 2018 | 66.74 | 0.00 | 0.00% | 66.74 | 66.74 | 66.74 |
NuVasive Events
Kellaaeg (UTC) (UTC) | Riik | Sündmus |
---|---|---|
No events scheduled |
- Aastas
- Kvartalis
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Kogutulu | 1201.94 | 1138.99 | 1050.58 | 1168.07 | 1101.71 |
Tulu | 1201.94 | 1138.99 | 1050.58 | 1168.07 | 1101.71 |
Kulud, Kokku | 336.507 | 322.278 | 321.631 | 312.357 | 311.159 |
Brutokasum | 865.435 | 816.71 | 728.951 | 855.713 | 790.555 |
Kogu tegevuskulu | 1113.53 | 1151.02 | 1012.28 | 1045.02 | 1047.55 |
Müük/Üldine/admin kulud, kokku | 634.095 | 610.085 | 547.195 | 611.181 | 575.836 |
Uuringud ja arendus | 98.524 | 92.626 | 79.838 | 72.38 | 61.695 |
Depreciation / Amortization | 49.376 | 57.309 | 51.726 | 51.097 | 50.67 |
Ootamatud kulutused (tulu) | -4.976 | 68.719 | 11.889 | -1.995 | 48.186 |
Tulud majandustegevusest | 88.416 | -12.029 | 38.303 | 123.05 | 54.168 |
Intressitulud (kulu), muud tulud, neto | 2.636 | -20.896 | -68.994 | -36.608 | -37.271 |
Muud, neto | -38.73 | -25.459 | -16.854 | -5.925 | -8.174 |
Netotulu enne makse | 52.322 | -58.384 | -47.545 | 80.517 | 8.723 |
Netotulu pärast makse | 40.407 | -64.086 | -37.153 | 65.234 | 12.479 |
Vähemuse intress | 0 | 0 | |||
Netotulu enne erikulusid | 40.407 | -64.086 | -37.153 | 65.234 | 12.479 |
Erakorralised kulud kokku | 0 | ||||
Netotulu | 40.407 | -64.086 | -37.153 | 65.234 | 12.479 |
Arvestatav tulu, v a erikulud | 40.407 | -64.086 | -37.153 | 65.234 | 12.479 |
Arvestatav tulu, koos erikuludega | 40.407 | -64.086 | -37.153 | 65.234 | 12.479 |
Jaotuse korrigeerimine | |||||
Jaotamisele kuuluv netotulu | 40.407 | -64.086 | -37.153 | 65.234 | 12.479 |
Keskmine jaotamisele kuuluv aktsia kohta | 57.359 | 51.589 | 51.416 | 53.16 | 52.355 |
Jaotatav EPS, v a erakorralised kulud | 0.70446 | -1.24224 | -0.7226 | 1.22713 | 0.23835 |
Dividends per Share - Common Stock Primary Issue | |||||
Jaotamisele kuuluv normaal-EPS | 0.63746 | -0.37641 | -0.56541 | 1.19672 | 0.89618 |
Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | |
---|---|---|---|---|---|
Kogutulu | 305.449 | 295.28 | 310.451 | 290.762 | 302.075 |
Tulu | 305.449 | 295.28 | 310.451 | 290.762 | 302.075 |
Kulud, Kokku | 90.78 | 80.872 | 85.758 | 79.097 | 83.535 |
Brutokasum | 214.669 | 214.408 | 224.693 | 211.665 | 218.54 |
Kogu tegevuskulu | 283.807 | 273.511 | 277.38 | 278.828 | 330.556 |
Müük/Üldine/admin kulud, kokku | 159.113 | 154.005 | 160.696 | 160.281 | 160.678 |
Uuringud ja arendus | 25.587 | 23.666 | 25.913 | 23.358 | 25.233 |
Depreciation / Amortization | 11.55 | 12.157 | 12.637 | 13.032 | 14.079 |
Ootamatud kulutused (tulu) | -3.223 | 2.811 | -7.624 | 3.06 | 47.031 |
Tulud majandustegevusest | 21.642 | 21.769 | 33.071 | 11.934 | -28.481 |
Intressitulud (kulu), muud tulud, neto | 49.394 | -24.532 | -33.69 | 11.664 | -4.277 |
Muud, neto | -39.04 | -0.053 | -0.081 | 0.244 | -1.12 |
Netotulu enne makse | 31.996 | -2.816 | -0.7 | 23.842 | -33.878 |
Netotulu pärast makse | 24.076 | -1.977 | -0.893 | 19.201 | -36.736 |
Netotulu enne erikulusid | 24.076 | -1.977 | -0.893 | 19.201 | -36.736 |
Netotulu | 24.076 | -1.977 | -0.893 | 19.201 | -36.736 |
Arvestatav tulu, v a erikulud | 24.076 | -1.977 | -0.893 | 19.201 | -36.736 |
Arvestatav tulu, koos erikuludega | 24.076 | -1.977 | -0.893 | 19.201 | -36.736 |
Jaotamisele kuuluv netotulu | 24.076 | -1.977 | -0.893 | 19.201 | -36.736 |
Keskmine jaotamisele kuuluv aktsia kohta | 71.9 | 52.067 | 52.022 | 62.579 | 51.739 |
Jaotatav EPS, v a erakorralised kulud | 0.33485 | -0.03797 | -0.01717 | 0.30683 | -0.71003 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | ||
Jaotamisele kuuluv normaal-EPS | 0.30112 | -0.00288 | -0.11243 | 0.34621 | -0.11917 |
- Aastas
- Kvartalis
2021 | 2020 | 2019 | 2018 | 2017 | |
---|---|---|---|---|---|
Käibevarad kokku | 802.424 | 1562.18 | 764.336 | 618.209 | 560.063 |
Raha ja lühiajalised investeeringud | 246.091 | 1030.01 | 213.034 | 117.84 | 72.803 |
Raha ja ekvivalendid | 246.091 | 856.869 | 213.034 | 117.84 | 72.803 |
Lühiajalised investeeringud | 0 | 173.145 | |||
Laekumata arved, neto | 214.398 | 207.071 | 211.532 | 196.487 | 200.22 |
Accounts Receivable - Trade, Net | 214.398 | 207.071 | 211.532 | 196.487 | 200.22 |
Total Inventory | 315.845 | 300.623 | 312.419 | 273.244 | 247.138 |
Prepaid Expenses | 26.09 | 24.476 | 27.351 | 30.638 | 36.001 |
Total Assets | 2154.07 | 2693.08 | 1885.29 | 1707.86 | 1640.14 |
Property/Plant/Equipment, Total - Net | 406.651 | 388.639 | 333.25 | 238.841 | 215.326 |
Property/Plant/Equipment, Total - Gross | 909.166 | 841.718 | 726.529 | 576.382 | |
Accumulated Depreciation, Total | -502.515 | -453.079 | -393.279 | -337.541 | |
Goodwill, Net | 633.467 | 559.553 | 561.064 | 561.366 | 536.926 |
Intangibles, Net | 242.675 | 152.264 | 201.092 | 252.048 | 280.774 |
Long Term Investments | |||||
Other Long Term Assets, Total | 68.858 | 30.442 | 25.548 | 37.395 | 47.051 |
Total Current Liabilities | 200.891 | 836.362 | 206.917 | 179.46 | 161.395 |
Accounts Payable | 16.192 | 17.386 | 11.827 | 8.799 | |
Accrued Expenses | 146.454 | 135.748 | 155.188 | 130.346 | 55.618 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Port. of LT Debt/Capital Leases | 0 | 645.303 | |||
Other Current Liabilities, Total | 38.245 | 37.925 | 39.902 | 40.315 | 30.01 |
Total Liabilities | 1358.87 | 1774.16 | 970.083 | 873.334 | 844.569 |
Total Long Term Debt | 885.869 | 772.735 | 624.203 | 602.526 | 582.92 |
Long Term Debt | 884.984 | 770.923 | 623.298 | 602.526 | 582.92 |
Deferred Income Tax | 3.049 | 2.807 | 14.655 | 4.964 | 18.87 |
Minority Interest | 0 | 3.845 | |||
Other Liabilities, Total | 269.059 | 162.26 | 124.308 | 86.384 | 77.539 |
Total Equity | 795.207 | 918.918 | 915.207 | 834.525 | 795.571 |
Common Stock | 0.063 | 0.062 | 0.062 | 0.061 | 0.06 |
Additional Paid-In Capital | 1434.98 | 1550 | 1429.85 | 1397.83 | 1363.55 |
Retained Earnings (Accumulated Deficit) | 45.708 | 45.322 | 82.475 | 17.241 | 4.762 |
Treasury Stock - Common | -677.748 | -668.882 | -587.766 | -571.978 | -565.867 |
Other Equity, Total | -7.792 | -7.585 | -9.418 | -8.628 | -6.933 |
Total Liabilities & Shareholders’ Equity | 2154.07 | 2693.08 | 1885.29 | 1707.86 | 1640.14 |
Total Common Shares Outstanding | 51.769 | 51.376 | 52.1451 | 51.5316 | 51.1622 |
Other Current Assets, Total | 3.901 | ||||
Payable/Accrued | 75.767 | ||||
Capital Lease Obligations | 0.885 | 1.812 | 0.905 |
Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | |
---|---|---|---|---|---|
Käibevarad kokku | 792.214 | 802.424 | 770.361 | 765.748 | 781.56 |
Raha ja lühiajalised investeeringud | 205.312 | 246.091 | 234.578 | 204.138 | 233.857 |
Raha ja ekvivalendid | 205.312 | 246.091 | 234.578 | 204.138 | 233.857 |
Lühiajalised investeeringud | 0 | 0 | 0 | 0 | |
Laekumata arved, neto | 231.425 | 214.398 | 199.366 | 216.915 | 205.026 |
Accounts Receivable - Trade, Net | 231.425 | 214.398 | 199.366 | 216.915 | 205.026 |
Total Inventory | 324.403 | 315.845 | 311.414 | 319.734 | 315.749 |
Prepaid Expenses | 31.074 | 26.09 | 25.003 | 24.961 | 26.928 |
Total Assets | 2160.5 | 2154.07 | 2134.03 | 2146.47 | 2164.78 |
Property/Plant/Equipment, Total - Net | 414.345 | 406.651 | 406.785 | 401.762 | 388.136 |
Goodwill, Net | 636.703 | 633.467 | 633.121 | 636.727 | 636.422 |
Intangibles, Net | 233.301 | 242.675 | 256.416 | 278.097 | 296.514 |
Other Long Term Assets, Total | 83.938 | 68.858 | 67.35 | 64.139 | 62.153 |
Total Current Liabilities | 248.729 | 200.891 | 195.362 | 193.732 | 224.876 |
Payable/Accrued | 115.674 | 115.614 | 110.796 | 110.702 | 106.576 |
Accrued Expenses | 65.891 | 76.463 | 75.368 | 74.306 | 66.908 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Port. of LT Debt/Capital Leases | 0 | 0 | 0 | 0 | |
Other Current Liabilities, Total | 67.164 | 8.814 | 9.198 | 8.724 | 51.392 |
Total Liabilities | 1348.58 | 1358.87 | 1309.84 | 1305.57 | 1329.4 |
Total Long Term Debt | 887.593 | 885.869 | 884.167 | 882.498 | 880.939 |
Long Term Debt | 886.793 | 884.984 | 883.18 | 881.381 | 879.473 |
Capital Lease Obligations | 0.8 | 0.885 | 0.987 | 1.117 | 1.466 |
Deferred Income Tax | 12.807 | 3.049 | 2.683 | 2.798 | 3.042 |
Other Liabilities, Total | 199.451 | 269.059 | 227.625 | 226.544 | 220.541 |
Total Equity | 811.921 | 795.207 | 824.196 | 840.901 | 835.387 |
Common Stock | 0.063 | 0.063 | 0.063 | 0.062 | 0.062 |
Additional Paid-In Capital | 1441.78 | 1434.98 | 1425.24 | 1420.28 | 1411.17 |
Retained Earnings (Accumulated Deficit) | 64.909 | 45.708 | 82.444 | 104.083 | 102.284 |
Treasury Stock - Common | -683.093 | -677.748 | -676.244 | -675.899 | -668.99 |
Other Equity, Total | -11.741 | -7.792 | -7.309 | -7.622 | -9.139 |
Total Liabilities & Shareholders’ Equity | 2160.5 | 2154.07 | 2134.03 | 2146.47 | 2164.78 |
Total Common Shares Outstanding | 51.949 | 51.769 | 51.677 | 51.665 | 51.379 |
Preferred Stock - Non Redeemable, Net | 0 | 0 | 0 |
- Aastas
- Kvartalis
2021 | 2020 | 2019 | 2018 | 2017 | |
---|---|---|---|---|---|
Netotulu/algväärtus | -64.086 | -37.153 | 65.234 | 12.479 | 79.855 |
Raha majandustegevusest | 182.174 | 185.911 | 235.29 | 219.183 | 176.969 |
Raha majandustegevusest | 149.524 | 140.937 | 135.593 | 129.765 | 121.176 |
Deferred Taxes | -4.141 | -18.007 | 5.844 | -11.396 | -12.838 |
Mittelikviidsed varad | 150.176 | 151.489 | 80.384 | 97.667 | 65.112 |
Cash Taxes Paid | 11.879 | 1.873 | 5.828 | 5.51 | 1.459 |
Makstud intressid | 16.294 | 19.914 | 16.145 | 17.182 | 15.897 |
Muutused tööjõus | -49.299 | -51.355 | -51.765 | -9.332 | -76.336 |
Tulu investeeringutelt | -136.065 | -281.934 | -134.484 | -161.285 | -174.861 |
Kapitalikulutused | -112.456 | -109.589 | -130.384 | -109.603 | -112.491 |
Muud rahavood investeeringutelt, kokku | -23.609 | -172.345 | -4.1 | -51.682 | -62.37 |
Rahavood investeeringutelt | -653.349 | 736.656 | -6.644 | -14.578 | -87.028 |
Rahavoogudesse investeerimine | -1.328 | -8.787 | 1.419 | -19.777 | -21.842 |
Aktsiate emiteerimine (tagasiost), neto | -2.595 | 19.42 | -8.063 | 5.199 | -1.869 |
Laenu väljastamine (kustutamine), neto | -649.426 | 726.023 | 0 | 0 | -63.317 |
Muutused valuutakursside kõikumisest | -3.538 | 3.202 | 0.131 | -1.283 | 2.07 |
Rahaline kogumuutus | -610.778 | 643.835 | 94.293 | 42.037 | -82.85 |
Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | |
---|---|---|---|---|---|
Net income/Starting Line | 19.201 | -64.086 | -27.35 | -5.711 | -7.51 |
Cash From Operating Activities | 6.539 | 182.174 | 144.77 | 79.396 | 31.639 |
Cash From Operating Activities | 36.801 | 149.524 | 111.818 | 73.954 | 36.432 |
Deferred Taxes | -3.891 | -4.141 | -5.211 | -2.942 | -3.535 |
Non-Cash Items | -7.717 | 150.176 | 89.929 | 50.951 | 33.315 |
Changes in Working Capital | -37.855 | -49.299 | -24.416 | -36.856 | -27.063 |
Cash From Investing Activities | -34.17 | -136.065 | -110.439 | -77.293 | -2.655 |
Capital Expenditures | -33.223 | -112.456 | -86.83 | -54.683 | -26.27 |
Other Investing Cash Flow Items, Total | -0.947 | -23.609 | -23.609 | -22.61 | 23.615 |
Cash From Financing Activities | -12.705 | -653.349 | -653.973 | -653.261 | -649.825 |
Financing Cash Flow Items | -7.36 | -1.328 | -1.041 | -0.674 | -0.344 |
Issuance (Retirement) of Stock, Net | -5.345 | -2.595 | -3.506 | -3.161 | -0.055 |
Issuance (Retirement) of Debt, Net | 0 | -649.426 | -649.426 | -649.426 | -649.426 |
Foreign Exchange Effects | -0.443 | -3.538 | -2.649 | -1.573 | -2.171 |
Net Change in Cash | -40.779 | -610.778 | -622.291 | -652.731 | -623.012 |
Investori nimi | Investori liik | Ringluse protsent | Hoitud osakud | Muutus osakutes | Hoidmise kuupäev | Hinnang käibele |
---|---|---|---|---|---|---|
BlackRock Institutional Trust Company, N.A. | Investment Advisor | 16.0321 | 8367512 | 2689624 | 2022-12-31 | LOW |
The Vanguard Group, Inc. | Investment Advisor/Hedge Fund | 11.9284 | 6225673 | 822094 | 2022-12-31 | LOW |
Thrivent Asset Management, LLC | Investment Advisor | 6.1686 | 3219514 | 647625 | 2022-12-31 | LOW |
Macquarie Investment Management | Investment Advisor | 4.4331 | 2313720 | -15467 | 2022-12-31 | LOW |
State Street Global Advisors (US) | Investment Advisor/Hedge Fund | 4.0595 | 2118756 | 285974 | 2022-12-31 | LOW |
Dimensional Fund Advisors, L.P. | Investment Advisor/Hedge Fund | 2.7738 | 1447731 | 106621 | 2022-12-31 | LOW |
Paradice Investment Management LLC | Investment Advisor | 2.6646 | 1390688 | 195605 | 2022-12-31 | LOW |
JP Morgan Asset Management | Investment Advisor | 2.4859 | 1297438 | -250697 | 2022-12-31 | LOW |
Channing Capital Management, LLC | Investment Advisor | 2.2594 | 1179211 | -71535 | 2022-12-31 | MED |
Geode Capital Management, L.L.C. | Investment Advisor/Hedge Fund | 1.851 | 966072 | 19879 | 2022-12-31 | LOW |
Magnetar Capital Partners LP | Investment Advisor/Hedge Fund | 1.6194 | 845201 | -46632 | 2022-12-31 | HIGH |
Arrowstreet Capital, Limited Partnership | Investment Advisor/Hedge Fund | 1.5754 | 822225 | 402045 | 2022-12-31 | MED |
Point72 Asset Management, L.P. | Hedge Fund | 1.5686 | 818700 | 818700 | 2022-12-31 | HIGH |
Stephens Investment Management Group, LLC | Investment Advisor | 1.5338 | 800504 | 2138 | 2022-12-31 | LOW |
Norges Bank Investment Management (NBIM) | Sovereign Wealth Fund | 1.5284 | 797685 | 282862 | 2022-12-31 | LOW |
Loomis, Sayles & Company, L.P. | Investment Advisor/Hedge Fund | 1.5109 | 788586 | -18861 | 2022-12-31 | LOW |
Frontier Capital Management Company, LLC | Investment Advisor | 1.4967 | 781140 | 12586 | 2022-12-31 | LOW |
Capital World Investors | Investment Advisor | 1.4677 | 766000 | 0 | 2022-12-31 | LOW |
Victory Capital Management Inc. | Investment Advisor/Hedge Fund | 1.3961 | 728657 | 90777 | 2022-12-31 | LOW |
Fisher Investments | Investment Advisor/Hedge Fund | 1.3731 | 716632 | -1699 | 2022-12-31 | LOW |
Miks valida Capital.com? Meie numbrid räägivad iseenda eest.
Capital.com Group500K+
Kauplejad
92K+
Igakuiste aktiivsete klientide arv
$53M+
Igakuine investeerimise maht
$30M+
Igakuiselt välja võetud
Kauplemiskalkulaator
Arvutage oma hüpoteetiline võit/kaotus, kui oleksite avanud CFD-tehingu ühel kindlal kuupäeval (valige kuupäev) ja sulgenud teisel kuupäeval (valige kuupäev).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
NuVasive Company profile
Ettevõttest NuVasive
NuVasive, Inc. on selgroo implantaatide arendaja, kes on ülemaailmne meditsiinitehnoloogia ettevõte, mis pakub integreeritud lahendusi lülisambakirurgia jaoks. Ettevõtte portfelli kuuluvad kirurgilise juurdepääsu instrumendid, lülisamba implantaadid, fikseerimissüsteemid, bioloogilised tooted, kirurgilise planeerimise tarkvara, navigatsiooni- ja pildistamislahendused ning intraoperatiivse neuromonitooringu tehnoloogia ja teenuste pakkumine. Ettevõtte kirurgilise juurdepääsu instrumentide hulka kuulub Maxcess integreeritud lõhestatud teraga retraktorsüsteem. Ettevõtte neuromonitooringu tarkvarapõhine närvide tuvastamise ja vältimise tehnoloogia ning intraoperatiivse neuromonitooringu teenused ja tugiteenused. Ettevõtte spetsiaalsete lülisambaimplantaatide Advanced Materials Science portfelli eesmärk on edendada lülisamba fusiooni, parandades implantaadimaterjalide, sealhulgas poorse titaani ja poorse polüeeter-ketooni (PEEK) osseointegratsiooni ja biomehaanilisi omadusi.
Industry: | Medical Equipment, Supplies & Distribution (NEC) |
7475 Lusk Blvd
SAN DIEGO
CALIFORNIA 92121
US
Tuluaruanne
- Annual
- Quarterly
Teised on vaadanud veel
Kas otsite jätkuvalt vahendajat, keda saab usaldada?
Ühinege 500,000+ kauplejaga üle kogu maailma, kes valisid kauplemiseks veebisaidi Capital.com